Genmab A/SGMABNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank79
3Y CAGR-0.4%
5Y CAGR+7.2%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-0.4%/yr
vs +48.0%/yr prior
5Y CAGR
+7.2%/yr
Recent deceleration
Acceleration
-48.4pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$14.32B-33.5%
2024$21.53B+30.7%
2023$16.47B+13.6%
2022$14.51B+72.3%
2021$8.42B-16.8%
2020$10.11B+88.4%
2019$5.37B+77.4%
2018$3.03B+27.9%
2017$2.37B+30.2%
2016$1.82B-